These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 11485976)
1. Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Silvestre JS; Mallat Z; Tamarat R; Duriez M; Tedgui A; Levy BI Circ Res; 2001 Aug; 89(3):259-64. PubMed ID: 11485976 [TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Silvestre JS; Mallat Z; Duriez M; Tamarat R; Bureau MF; Scherman D; Duverger N; Branellec D; Tedgui A; Levy BI Circ Res; 2000 Sep; 87(6):448-52. PubMed ID: 10988235 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Mallat Z; Silvestre JS; Le Ricousse-Roussanne S; Lecomte-Raclet L; Corbaz A; Clergue M; Duriez M; Barateau V; Akira S; Tedgui A; Tobelem G; Chvatchko Y; Lévy BI Circ Res; 2002 Sep; 91(5):441-8. PubMed ID: 12215494 [TBL] [Abstract][Full Text] [Related]
4. Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Roralpha. Besnard S; Silvestre JS; Duriez M; Bakouche J; Lemaigre-Dubreuil Y; Mariani J; Levy BI; Tedgui A Circ Res; 2001 Dec; 89(12):1209-15. PubMed ID: 11739287 [TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Tamarat R; Silvestre JS; Kubis N; Benessiano J; Duriez M; deGasparo M; Henrion D; Levy BI Hypertension; 2002 Mar; 39(3):830-5. PubMed ID: 11897773 [TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Silvestre JS; Tamarat R; Senbonmatsu T; Icchiki T; Ebrahimian T; Iglarz M; Besnard S; Duriez M; Inagami T; Lévy BI Circ Res; 2002 May; 90(10):1072-9. PubMed ID: 12039796 [TBL] [Abstract][Full Text] [Related]
7. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Silvestre JS; Bergaya S; Tamarat R; Duriez M; Boulanger CM; Levy BI Circ Res; 2001 Oct; 89(8):678-83. PubMed ID: 11597990 [TBL] [Abstract][Full Text] [Related]
8. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Rivard A; Silver M; Chen D; Kearney M; Magner M; Annex B; Peters K; Isner JM Am J Pathol; 1999 Feb; 154(2):355-63. PubMed ID: 10027394 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-19 increases angiogenesis in ischemic hind limbs by direct effects on both endothelial cells and macrophage polarization. Richards J; Gabunia K; Kelemen SE; Kako F; Choi ET; Autieri MV J Mol Cell Cardiol; 2015 Feb; 79():21-31. PubMed ID: 25450612 [TBL] [Abstract][Full Text] [Related]
11. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Tamarat R; Silvestre JS; Huijberts M; Benessiano J; Ebrahimian TG; Duriez M; Wautier MP; Wautier JL; Lévy BI Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8555-60. PubMed ID: 12805564 [TBL] [Abstract][Full Text] [Related]
12. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells. Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425 [TBL] [Abstract][Full Text] [Related]
13. Mouse model of angiogenesis. Couffinhal T; Silver M; Zheng LP; Kearney M; Witzenbichler B; Isner JM Am J Pathol; 1998 Jun; 152(6):1667-79. PubMed ID: 9626071 [TBL] [Abstract][Full Text] [Related]
14. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs. Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240 [TBL] [Abstract][Full Text] [Related]
16. SI-27, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity: detection with a variable-pressure scanning electron microscope. Yoshida D; Noha M; Watanabe K; Sugisaki Y; Teramoto A Neurosurgery; 2002 Mar; 50(3):578-86; discussion 586-8. PubMed ID: 11841727 [TBL] [Abstract][Full Text] [Related]
17. LOX-1 plays an important role in ischemia-induced angiogenesis of limbs. Shiraki T; Aoyama T; Yokoyama C; Hayakawa Y; Tanaka T; Nishigaki K; Sawamura T; Minatoguchi S PLoS One; 2014; 9(12):e114542. PubMed ID: 25514797 [TBL] [Abstract][Full Text] [Related]
18. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer. Hotz HG; Hines OJ; Hotz B; Foitzik T; Buhr HJ; Reber HA J Gastrointest Surg; 2003 Feb; 7(2):220-7; discussion 227-8. PubMed ID: 12600446 [TBL] [Abstract][Full Text] [Related]
20. Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathway. Iglarz M; Silvestre JS; Duriez M; Henrion D; Lévy BI Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1598-603. PubMed ID: 11597932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]